Bristol-Myers Squibb v. The Super. Ct. of S.F. Cnty.
(U.S., filed March 8, 2017): Arguing that it is improper for California courts to exercise specific personal jurisdiction over a company that has no connection whatsoever to California, except for the fact that its product is sold in the state.
On, June 19, 2017, the US Supreme Court agreed with ATRA’s amicus brief position and ruled that state courts do not have jurisdiction to hear their claims.
ATRA praises the passage of HB 6030 in Michigan, enacting COVID-19 liability protections.
ATRA’s statement on the Supreme Court of Pennsylvania’s ruling in Hammons v. Ethicon to allow an out-of-state lawsuit to continue, openly defying SCOTUS precedent.
Amanda Bronstad with Law.com writes about the potential repercussions if the 2019 $465 million judgment against Johnson & Johnson stands.
ATRA files amicus brief in support of Johnson & Johnson’s decision to appeal a 2019 $465 million judgment against the company, warning against the state attorney general’s expansive use of public nuisance law.
ATRA President Tiger Joyce spoke with Juliette Farley of the Southern California Record about Lawsuit Abuse Awareness Week and business interruption lawsuits.